Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This is a brief inpatient study to determine the safety of a new drug in healthy people.

Key facts

Study ID

NCT01851603

Run by

University of Colorado, Denver

People needed

12

Starts

2013-06-01

Expected to finish

2016-08-01

Last updated by the study team

2016-12-30

Who can join

Age: 18 and older, up to 70. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteer

You may not qualify if…

• Substance use. We do not accept inquiries by email.

Where it is running

• U of Colorado Denver — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.